Regulatory claims made by US businesses engaged in direct-to-consumer marketing of purported stem cell treatments and exosome therapies
Conclusion: The absence of information addressing the regulatory status of stem cell interventions and exosome products and the use of what appeared to be inaccurate information concerning the regulatory status of numerous products likely complicates efforts by customers to make informed health-related decisions.PMID:37867326 | DOI:10.2217/rme-2023-0117 (Source: Regenerative Medicine)
Source: Regenerative Medicine - October 23, 2023 Category: Genetics & Stem Cells Authors: Leigh Turner Juan Ramon Martinez Shemms Najjar Thevin Rajapaksha Arachchilage Victoria Sahrai Jia Chieng Wang Source Type: research
Regulatory claims made by US businesses engaged in direct-to-consumer marketing of purported stem cell treatments and exosome therapies
Conclusion: The absence of information addressing the regulatory status of stem cell interventions and exosome products and the use of what appeared to be inaccurate information concerning the regulatory status of numerous products likely complicates efforts by customers to make informed health-related decisions.PMID:37867326 | DOI:10.2217/rme-2023-0117 (Source: Regenerative Medicine)
Source: Regenerative Medicine - October 23, 2023 Category: Genetics & Stem Cells Authors: Leigh Turner Juan Ramon Martinez Shemms Najjar Thevin Rajapaksha Arachchilage Victoria Sahrai Jia Chieng Wang Source Type: research
Regulatory claims made by US businesses engaged in direct-to-consumer marketing of purported stem cell treatments and exosome therapies
Conclusion: The absence of information addressing the regulatory status of stem cell interventions and exosome products and the use of what appeared to be inaccurate information concerning the regulatory status of numerous products likely complicates efforts by customers to make informed health-related decisions.PMID:37867326 | DOI:10.2217/rme-2023-0117 (Source: Regenerative Medicine)
Source: Regenerative Medicine - October 23, 2023 Category: Genetics & Stem Cells Authors: Leigh Turner Juan Ramon Martinez Shemms Najjar Thevin Rajapaksha Arachchilage Victoria Sahrai Jia Chieng Wang Source Type: research
Regulatory claims made by US businesses engaged in direct-to-consumer marketing of purported stem cell treatments and exosome therapies
Conclusion: The absence of information addressing the regulatory status of stem cell interventions and exosome products and the use of what appeared to be inaccurate information concerning the regulatory status of numerous products likely complicates efforts by customers to make informed health-related decisions.PMID:37867326 | DOI:10.2217/rme-2023-0117 (Source: Regenerative Medicine)
Source: Regenerative Medicine - October 23, 2023 Category: Genetics & Stem Cells Authors: Leigh Turner Juan Ramon Martinez Shemms Najjar Thevin Rajapaksha Arachchilage Victoria Sahrai Jia Chieng Wang Source Type: research
Regulatory claims made by US businesses engaged in direct-to-consumer marketing of purported stem cell treatments and exosome therapies
Conclusion: The absence of information addressing the regulatory status of stem cell interventions and exosome products and the use of what appeared to be inaccurate information concerning the regulatory status of numerous products likely complicates efforts by customers to make informed health-related decisions.PMID:37867326 | DOI:10.2217/rme-2023-0117 (Source: Regenerative Medicine)
Source: Regenerative Medicine - October 23, 2023 Category: Genetics & Stem Cells Authors: Leigh Turner Juan Ramon Martinez Shemms Najjar Thevin Rajapaksha Arachchilage Victoria Sahrai Jia Chieng Wang Source Type: research
Regulatory claims made by US businesses engaged in direct-to-consumer marketing of purported stem cell treatments and exosome therapies
Conclusion: The absence of information addressing the regulatory status of stem cell interventions and exosome products and the use of what appeared to be inaccurate information concerning the regulatory status of numerous products likely complicates efforts by customers to make informed health-related decisions.PMID:37867326 | DOI:10.2217/rme-2023-0117 (Source: Regenerative Medicine)
Source: Regenerative Medicine - October 23, 2023 Category: Genetics & Stem Cells Authors: Leigh Turner Juan Ramon Martinez Shemms Najjar Thevin Rajapaksha Arachchilage Victoria Sahrai Jia Chieng Wang Source Type: research
Animal models in peripheral nerve transection studies: a systematic review on study design and outcomes assessment
Conclusion: There has not been a significant scale-up of the in vivo testing to large animal models (anatomically/physiologically closer to humans), allowing an improvement in translational medicine for clinical cases.PMID:37855207 | DOI:10.2217/rme-2023-0102 (Source: Regenerative Medicine)
Source: Regenerative Medicine - October 19, 2023 Category: Genetics & Stem Cells Authors: Bruna Lopes Andr é Coelho Rui Alvites Ana Catarina Sousa Patr ícia Sousa Al ícia Moreira Lu ís Atayde Ant ónio Salgado Stefano Geuna Ana Colette Maur ício Source Type: research
Animal models in peripheral nerve transection studies: a systematic review on study design and outcomes assessment
Conclusion: There has not been a significant scale-up of the in vivo testing to large animal models (anatomically/physiologically closer to humans), allowing an improvement in translational medicine for clinical cases.PMID:37855207 | DOI:10.2217/rme-2023-0102 (Source: Regenerative Medicine)
Source: Regenerative Medicine - October 19, 2023 Category: Genetics & Stem Cells Authors: Bruna Lopes Andr é Coelho Rui Alvites Ana Catarina Sousa Patr ícia Sousa Al ícia Moreira Lu ís Atayde Ant ónio Salgado Stefano Geuna Ana Colette Maur ício Source Type: research
Animal models in peripheral nerve transection studies: a systematic review on study design and outcomes assessment
Conclusion: There has not been a significant scale-up of the in vivo testing to large animal models (anatomically/physiologically closer to humans), allowing an improvement in translational medicine for clinical cases.PMID:37855207 | DOI:10.2217/rme-2023-0102 (Source: Regenerative Medicine)
Source: Regenerative Medicine - October 19, 2023 Category: Genetics & Stem Cells Authors: Bruna Lopes Andr é Coelho Rui Alvites Ana Catarina Sousa Patr ícia Sousa Al ícia Moreira Lu ís Atayde Ant ónio Salgado Stefano Geuna Ana Colette Maur ício Source Type: research
Animal models in peripheral nerve transection studies: a systematic review on study design and outcomes assessment
Conclusion: There has not been a significant scale-up of the in vivo testing to large animal models (anatomically/physiologically closer to humans), allowing an improvement in translational medicine for clinical cases.PMID:37855207 | DOI:10.2217/rme-2023-0102 (Source: Regenerative Medicine)
Source: Regenerative Medicine - October 19, 2023 Category: Genetics & Stem Cells Authors: Bruna Lopes Andr é Coelho Rui Alvites Ana Catarina Sousa Patr ícia Sousa Al ícia Moreira Lu ís Atayde Ant ónio Salgado Stefano Geuna Ana Colette Maur ício Source Type: research
Electrospun aligned tacrolimus-loaded polycaprolactone biomaterials for peripheral nerve repair
Conclusion: Electrospun PCL scaffolds with tacrolimus hold promise for the repair of peripheral nerve injury.PMID:37818696 | DOI:10.2217/rme-2023-0151 (Source: Regenerative Medicine)
Source: Regenerative Medicine - October 11, 2023 Category: Genetics & Stem Cells Authors: Holly N Gregory Owein Guillemot-Legris Daisy Crouch Gareth Williams James B Phillips Source Type: research
Electrospun aligned tacrolimus-loaded polycaprolactone biomaterials for peripheral nerve repair
Conclusion: Electrospun PCL scaffolds with tacrolimus hold promise for the repair of peripheral nerve injury.PMID:37818696 | DOI:10.2217/rme-2023-0151 (Source: Regenerative Medicine)
Source: Regenerative Medicine - October 11, 2023 Category: Genetics & Stem Cells Authors: Holly N Gregory Owein Guillemot-Legris Daisy Crouch Gareth Williams James B Phillips Source Type: research
Electrospun aligned tacrolimus-loaded polycaprolactone biomaterials for peripheral nerve repair
Conclusion: Electrospun PCL scaffolds with tacrolimus hold promise for the repair of peripheral nerve injury.PMID:37818696 | DOI:10.2217/rme-2023-0151 (Source: Regenerative Medicine)
Source: Regenerative Medicine - October 11, 2023 Category: Genetics & Stem Cells Authors: Holly N Gregory Owein Guillemot-Legris Daisy Crouch Gareth Williams James B Phillips Source Type: research
Electrospun aligned tacrolimus-loaded polycaprolactone biomaterials for peripheral nerve repair
Conclusion: Electrospun PCL scaffolds with tacrolimus hold promise for the repair of peripheral nerve injury.PMID:37818696 | DOI:10.2217/rme-2023-0151 (Source: Regenerative Medicine)
Source: Regenerative Medicine - October 11, 2023 Category: Genetics & Stem Cells Authors: Holly N Gregory Owein Guillemot-Legris Daisy Crouch Gareth Williams James B Phillips Source Type: research
Electrospun aligned tacrolimus-loaded polycaprolactone biomaterials for peripheral nerve repair
Conclusion: Electrospun PCL scaffolds with tacrolimus hold promise for the repair of peripheral nerve injury.PMID:37818696 | DOI:10.2217/rme-2023-0151 (Source: Regenerative Medicine)
Source: Regenerative Medicine - October 11, 2023 Category: Genetics & Stem Cells Authors: Holly N Gregory Owein Guillemot-Legris Daisy Crouch Gareth Williams James B Phillips Source Type: research
